From harnessing next-generation AI to transform clinical, regulatory and safety processes, to rethinking communications strategies from the earliest stages of product conception, life sciences organisations are heeding the call to do things differently – with a view to delivering better results, and boosting efficiency, for patients.
As 2024 gives way to 2025, we assess the progress being made and the emerging challenges and opportunities for the coming year, including a need to ramp up data science capabilities.
Across life sciences, the drive to be more efficient while complying with the latest standards for product quality and safety, is increasing the impetus for process transformation.
Check out the rest of the feature here
